IP Library Granted Patent US 11,939,342
Granted Patent B2
US 11,939,342 · App. 17/426,356 · Granted Mar 26, 2024

Process for the preparation of midostaurin with high purity

Inventors: Alberto Lena (Cameri, IT); Antonio Toppino (Cameri, IT); Katia Miele (Settala, IT); Jacopo Roletto (Cameri, IT); Paolo Paissoni (Cameri, IT)
Assignee: PROCOS S.P.A.
C07D498/22
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,939,342
App. No.
17/426,356
Granted
Mar 26, 2024
Kind
B2
Abstract

A process for the preparation of midostaurin with high purity, particularly a process for the preparation of midostaurin with a content of oxidation impurities lower than 0.1% comprising the treatment of crude midostaurin or staurosporine with strong organic or inorganic acids in a water-immiscible solvent and, optionally, also with reducing silanes is described.

Claims (20)

1. A process for the preparation of midostaurin with high purity, that is with a content of 3-hydroxymidostaurin impurities (III) and (IV) lower than 0.1%, comprising treating crude midostaurin with strong organic or inorganic acids in a water-immiscible solvent and, optionally, also with reducing silanes.

2. The process according to claim 1 , further comprising treating the crude midostaurin with a reducing silane.

3. A process for the preparation of midostaurin with high purity, that is with a content of 3-hydroxymidostaurin impurities (III) and (IV) lower than 0.1%, comprising treating crude staurosporine with a strong organic or inorganic acid, optionally with the concomitant addition of a reducing silane.

4. The process according to claim 1 , wherein the water-immiscible solvent is an aprotic polar water-immiscible solvent.

5. The process according to claim 4 wherein the water-immiscible solvent is dichloromethane, dichloroethane, methyl tetrahydrofuran or methylethylketone.

6. The process according to claim 1 , wherein the strong acid is trifluoroacetic acid.

7. The process according to claim 1 , wherein the reducing silane is triethylsilane.

8. The process according to claim 3 , further comprising the benzoylation reaction of staurosporine to midostaurin wherein the benzoylation reaction is quenched with an aqueous solution having a slightly acid pH.

9. The process according to claim 8 wherein the aqueous solution having a slightly acid pH is an aqueous ammonium chloride solution.

10. The process of claim 1 , wherein the purified midostaurin is obtained by crystallization from 2-MeTHF and is isolated by:

dissolving the crystallized midostaurin in a water-miscible polar solvent,

adding water

isolating purified midostaurin as an amorphous solid obtained by filtering and drying, with a content of organic solvents <50 ppm.

11. The process for the preparation of purified midostaurin according to claim 10 , wherein the polar solvent is ethanol.

12. The process according to claim 5 , wherein the water-immiscible solvent is dichloromethane.

13. The process according to claim 3 , wherein the water-immiscible solvent is an aprotic polar water-immiscible solvent.

14. The process according to claim 13 wherein the water-immiscible solvent is dichloromethane, dichloroethane, methyl tetrahydrofuran or methylethylketone.

15. The process according to claim 14 , wherein the water-immiscible solvent is dichloromethane.

16. The process according to claim 3 , wherein the strong acid is trifluoroacetic acid.

17. The process according to claim 3 , wherein the reducing silane is triethylsilane.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 28, 2021
From: LENA, ALBERTO; TOPPINO, ANTONIO; MIELE, KATIA; ROLETTO, JACOPO; PAISSONI, PAOLO
To: PROCOS S.P.A.
Reel/Frame 057005/0141 →
Priority Claims (1)
IT 102019000004729 · Mar 29, 2019 · national
Continuity (1)
Related Publication 20220098216A1 · Mar 31, 2022